You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR GEODON

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for GEODON

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00044655 ↗	Switching Medication to Treat Schizophrenia	Completed	National Institute of Mental Health (NIMH)	Phase 4	2001-07-01	This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
NCT00044655 ↗	Switching Medication to Treat Schizophrenia	Completed	Icahn School of Medicine at Mount Sinai	Phase 4	2001-07-01	This study will evaluate the effectiveness of switching medications in decreasing schizophrenia symptoms in individuals who are currently taking an antipsychotic medication for the treatment of schizophrenia.
NCT00141271 ↗	A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression	Completed	Pfizer	Phase 3	2005-07-01	This is a 6-week trial that evaluates the efficacy and safety of Geodon (ziprasidone) in outpatient subjects ages 18 and older with Bipolar Disorder type I, depressed. Subjects are required to undergo a washout period of at least 7 days of any prior med.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for GEODON

Condition Name

Chart
Table

Condition Name for GEODON
Intervention	Trials
Schizophrenia	17
Bipolar Disorder	15
Schizoaffective Disorder	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for GEODON
Intervention	Trials
Disease	17
Schizophrenia	17
Bipolar Disorder	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for GEODON

Trials by Country

Map
Table

Trials by Country for GEODON
Location	Trials
United States	181
India	14
Malaysia	5
Russian Federation	4
Ukraine	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for GEODON
Location	Trials
New York	14
Massachusetts	13
California	12
Texas	11
Ohio	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for GEODON

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for GEODON
Clinical Trial Phase	Trials
Phase 4	15
Phase 3	8
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for GEODON
Clinical Trial Phase	Trials
Completed	38
Terminated	7
Unknown status	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for GEODON

Sponsor Name

Chart
Table

Sponsor Name for GEODON
Sponsor	Trials
Pfizer	25
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	8
Massachusetts General Hospital	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for GEODON
Sponsor	Trials
Other	64
Industry	37
NIH	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.